Smt Cardiovascular Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.22 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 145.14 Cr
- Revenue Growth 16006.70%
- Profit Growth -105.90%
- Ebitda 153.67%
- Net Worth 170.52%
- Total Assets 17.95%
About Smt Cardiovascular
Smt Cardiovascular Private Limited (SCPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 November 2019 (Five years and four months 12 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.22 M.
The company currently has active open charges totaling ₹145.14 Cr.
Bhargav Kotadia and Ganesh Sabat serve as directors at the Company.
Company Details
- Location
Surat, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33302GJ2019PTC110835
- Company No.
110835
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2019
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Healthcare
Who are the key members and board of directors at Smt Cardiovascular?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesh Sabat  | Director | 16-Nov-2019 | Current |
| Bhargav Kotadia | Director | 16-Nov-2019 | Current |
Financial Performance of Smt Cardiovascular.
Smt Cardiovascular Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16006.7% increase. The company also saw a substantial fall in profitability, with a 105.9% decrease in profit. The company's net worth Soared by an impressive increase of 170.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Smt Cardiovascular?
In 2023, Smt Cardiovascular had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sahajanand Medical Technologies LimitedBhargav Kotadia and Ganesh Sabat are mutual person
Charges (Loans)
Open Charges
₹1,451.37 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Standard Chartered Bank : 100.00 Cr
- Others : 45.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Apr 2024 | Others | ₹45.14 Cr | Open |
| 13 Apr 2020 | Standard Chartered Bank | ₹100.00 Cr | Open |
How Many Employees Work at Smt Cardiovascular?
Smt Cardiovascular has a workforce of 104 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smt Cardiovascular, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smt Cardiovascular's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Smt Cardiovascular
Recent activity within the organization
- Annual General Meeting
Smt Cardiovascular Private Limited last Annual general meeting of members was held on 26 Sep 2024 as per latest MCA records.
- Charges
A charge with Others amounted to Rs. 451.37 M with Charge ID 100954287 was registered on 15 Apr 2024.
- Balance Sheet
Smt Cardiovascular Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
- Charges
A charge with Standard Chartered Bank of Rs. 1,000.00 M registered on 13 Apr 2020 with Charge ID 100335488 was modified on 28 Apr 2023.
- Charges
A charge with Standard Chartered Bank amounted to Rs. 1,000.00 M with Charge ID 100335488 was registered on 13 Apr 2020.
- Director Appointment
Bhargav Dhirajlal Kotadia was appointed as a Director was appointed as a Director on 16 Nov 2019 & has been associated with this company since 5 years 4 months .
Recent News, Updates & Announcement
- SMT Invests 250 Cr in Telangana, Boosting Medical Device Industry; KTR Applauds Company's Success in 'Make in India' Initiative.
SMT invests 250 Cr in Telangana for medical device unit. KTR happy. SMT makes stents and catheters, creates jobs. Founded in 2001, supports 'Make in India'. Biggest in India, exports to 60+ countries. Has plant in Gujarat and R&D centers. First to get CE certification for drug-eluting stent. Customer-focused and sells directly..
- Indian Stent Supraflex Proven Equal to Global Standard Xience in TALENT Study, SMT Leads the Way in Life-Saving Vascular Solutions.
Indian stent Supraflex confirmed as good as global standard Xience in TALENT study. Supraflex made by SMT, Indian company specializing in life-changing vascular solutions. Study conducted in 7 countries with 1435 patients. Supraflex has better efficacy and lower re-procedure rate. Available in 65 countries, largest selling stent in India. Advanced features like biodegradable polymer and ultra-thin struts. TALENT results match published meta-analysis. CEO proud of India's success in life-saving technology industry. Over 5,00,000 stents used in India every year. Drug eluting stents help prevent artery narrowing after surgery..
Frequently asked questions
What is the Incorporation or founding date of Smt Cardiovascular Private Limited?
Smt Cardiovascular Private Limited was incorporated on 16 Nov 2019.
What is authorized share capital and paid-up capital of Smt Cardiovascular Private Limited?
The authorized share capital of Smt Cardiovascular Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.22 M.
Who are the current board members & directors of Smt Cardiovascular Private Limited?
Currently 2 directors are associated with Smt Cardiovascular Private Limited.
- Bhargav Dhirajlal Kotadia
- Ganesh Prasad Sabat
What is the registered address of Smt Cardiovascular Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Smt Cardiovascular Private Limited is Sahajanand Estate Wakharia Wadi Near Dabholi Char Rasta Nani Ved Ved Road, India, Surat, Gujarat, 395004.
What is the corporate identification number (CIN) and company number of Smt Cardiovascular Private Limited?
The corporate identification number (CIN) of Smt Cardiovascular Private Limited is U33302GJ2019PTC110835 and the company number is 110835 as per Ministry of Corporate Affairs (MCA).
What is the official website of Smt Cardiovascular Private Limited?
The Official website of Smt Cardiovascular Private Limited is https://www.smtpl
What has been the recent revenue trend for Smt Cardiovascular Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Smt Cardiovascular Private Limited has risen by 16006.70%.
How many employees does Smt Cardiovascular Private Limited currently have?
As Per 2023 financial reports, 104 employees are currently employed by Smt Cardiovascular Private Limited.
What change has been observed in the net worth of Smt Cardiovascular Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Smt Cardiovascular Private Limited has experienced an upsurge of 170.52%.
What are the total open charges for Smt Cardiovascular Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Smt Cardiovascular Private Limited amount to ₹ 145.14 Cr.
When was the last Balance Sheet of Smt Cardiovascular Private Limited filed with the ROC?
The most recent Balance Sheet for Smt Cardiovascular Private Limited was filed with the ROC on 31 Mar 2024.